Anti-Vimentin

In 1X PBS, pH 7.4, with 0.09% sodium azide. Vimentin (VIM) is a type III intermediate filament protein that serves as a central marker of mesenchymal identity and epithelial-mesenchymal transition in both normal biology and cancer progression. Vimentin Antibody for IF / EMT Marker Antibody is specifically designed for immunofluorescence-based detection of EMT-associated Vimentin expression, enabling visualization of mesenchymal phenotypes and cellular plasticity at the single-cell level. This aligns strongly with search intent such as Vimentin EMT antibody, VIM IF antibody for EMT, and EMT marker antibody for immunofluorescence. Vimentin is also referred to as Vimentin antibody, VIM antibody, and mesenchymal marker antibody in the literature, supporting strong alignment across gene, protein, and disease-focused terminology.In immunofluorescence imaging, Vimentin is strongly upregulated during epithelial-mesenchymal transition, where epithelial cells lose polarity and cell-cell adhesion while acquiring migratory, invasive, and stem-like characteristics. The Vimentin Antibody for IF / EMT Marker Antibody enables direct visualization of this transition by highlighting cytoplasmic filamentous Vimentin expression in EMT-positive cells, often in contrast to epithelial markers such as cytokeratins. This contrast is critical for identifying transitioning cell populations within heterogeneous tumors and for mapping EMT-driven changes in cell state during cancer progression.Vimentin expression is prominent in fibroblasts, endothelial cells, immune cells, and mesenchymal-like tumor cells, where it supports cytoskeletal remodeling, migration, and tissue invasion. In fluorescence-based workflows, the Vimentin Antibody for IF / EMT Marker Antibody is widely used to study tumor microenvironment composition, stromal activation, and EMT-associated phenotypes. It is particularly valuable in co-localization experiments, where Vimentin is analyzed alongside epithelial markers, stem cell markers, or signaling proteins to define distinct cellular states and transitional populations within complex tissues.Functionally, Vimentin interacts with actin filaments and microtubules to regulate cell shape, adhesion, and motility, all of which are essential during EMT and metastatic progression. Its dynamic reorganization through phosphorylation supports cytoskeletal flexibility required for invasion and migration. The Vimentin Antibody for IF / EMT Marker Antibody differentiator is central to this antibody, positioning it specifically for fluorescence imaging studies of tumor plasticity, invasive behavior, and epithelial-to-mesenchymal transition. A rabbit polyclonal Vimentin Antibody for IF provides strong fluorescent signal and enables sensitive detection of Vimentin / VIM expression in EMT-active cell populations, supporting advanced cancer biology and cell state research.